Recent quality and operational issues at Smiths, which originated before it was purchased, greatly reduced ICU’s gross margin after the acquisition. These issues have required additional spending to ...

An increasing prevalence of chronic diseases is expected to drive the global infusion pump market to rise by $4.99b through ...

Avanos Medical announced today that a Centers for Medicare and Medicaid Services (CMS) payment rule benefits its infusion ...

In the final rule, CMS confirmed that both the Avanos ON-Q elastomeric infusion pump and the Avanos ambIT disposable electronic infusion pump non-opioid pain management delivery systems meet ...

When facing colorectal liver metastases or colorectal cancer that has spread to the liver, finding effective treatment options can be challenging. Dr. Katherine Poruk, a surgical oncologist at Mayo ...

Infusion therapy is often used to deliver certain disease-modifying therapies (DMTs) to patients with MS. DMTs suppress specific actions by the immune system to slow its attack on nerve cells.

The U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD). Vyalev is the first and only ...

These jobs are part of BD’s top revenue-driving business segment, BD Medical. One product of the BD unit are infusion pumps and syringes for IV drips in hospitals. A company spokesperson said that in ...

The tubed pumps are as small as a beeper or phone and have a tube connecting the device to an infusion site on the user. I wear a tubeless pump called an Omnipod. This is a disposable, wearable ...

It’s administered through an infusion pump to slowly deliver the medication over a period of time under your skin. Your doctor or another healthcare professional will administer your Rystiggo doses.

Vyalev combines foscarbidopa, a prodrug of carbidopa, and foslevodopa, a prodrug of levodopa, into a solution for continuous subcutaneous 24-hour infusion. The Food and Drug Administration (FDA ...